Invention Grant
- Patent Title: Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells
-
Application No.: US16613355Application Date: 2017-05-15
-
Publication No.: US11413311B2Publication Date: 2022-08-16
- Inventor: Ehud Marom , Nadav Bleich Kimelman , Frida Grynspan
- Applicant: STEM CELL MEDICINE LTD. , MAPI PHARMA LTD.
- Applicant Address: IL Jerusalem; IL Ness Ziona
- Assignee: STEM CELL MEDICINE LTD.,MAPI PHARMA LTD.
- Current Assignee: STEM CELL MEDICINE LTD.,MAPI PHARMA LTD.
- Current Assignee Address: IL Jerusalem; IL Ness Ziona
- Agency: Rothwell, Figg, Ernst & Manbeck, P.C.
- International Application: PCT/IL2017/050535 WO 20170515
- International Announcement: WO2018/211486 WO 20181122
- Main IPC: A61K35/28
- IPC: A61K35/28 ; A61P25/00 ; A61K38/02 ; A61K9/00
Abstract:
Methods of treating multiple sclerosis are provided, comprising parenterally administering glatiramer acetate in a sustained-release depot form, and administering adipose-derived stem cells into the central nervous system. According to some aspects the combined treatments provide synergistic effects. In particular the combined therapies offer benefits to progressive forms of multiple sclerosis.
Public/Granted literature
- US20200147141A1 TREATMENT OF MULTIPLE SCLEROSIS WITH LONG ACTING GLATIRAMER AND ADIPOSE-DERIVED STEM CELLS Public/Granted day:2020-05-14
Information query
IPC分类:
